Skip to main content
Clinical Trials/NCT06221150
NCT06221150CompletedNot Applicable

Ultrasound-guided Bilateral Two Levels Serratus Anterior Plane Block in Pediatric Cardiac Surgery With Median Sternotomy : A Randomized Controlled Trial

Cairo University1 site in 1 country48 target enrollmentStarted: January 20, 2025Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
Postoperative Fentanyl consumption

Study Overview

Brief Summary

The serratus anterior plane block (SAPB) is an anterolateral thoracic wall block that was described in 2013 by Blanco et al. who presented it as an alternative to other regional anesthetic techniques. It has been described in adults as an adjunct to general anesthesia or as a primary anesthetic technique for breast surgery, it has not been widely utilized as a primary anesthetic technique in the pediatric population. It was designed to block primarily the thoracic intercostal nerves and to provide complete analgesia of the lateral part of the thorax. It provides a viable alternative to paravertebral blockade and central neuraxial block in this patient population The investigators believe that the bilateral two-level injection technique may provide effective analgesia as its efficacy was not properly investigated in corrective heart surgeries with median sternotomy in the pediatric population.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
6 Months to 6 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Risk Adjustment for Congenital Heart Surgery (RACHS) category 1,2 and 3 Pediatric patients undergoing corrective congenital cardiac surgeries via a median sternotomy

Exclusion Criteria

  • •Refusal of legal guardian.
  • •Patient with congestive heart failure .
  • •Patient undergoing Redo cardiac surgery.
  • •Known allergy to local anesthetics.
  • •Infection at injection site.
  • •Bleeding disorders (drug induced i.e., coumadin; or genetic i.e. hemophilia; or acquired i.e. DIC), coagulopathy: PTT > 40 seconds, INR > 1.4, platelet count < 100x10⁹.
  • •severe renal impairment (estimated Glomerular filtration rate less than 30ml/min/1.73m2) or hepatic insufficiency (Child-Pugh Class B and C).
  • •Neurological disorders because it will be difficult to assess their pain score (e.g. cerebral palsy).

Arms & Interventions

control group

No Intervention

Intraoperative fentanyl without nerve block

SAPB group

Experimental

bilateral two-level SAPB is performed with the guidance of ultrasound. While the patient is in the supine position with their arms abducted, the US probe is placed in longitudinal plane to visualize and count the ribs down from the clavicle while moving the transducer laterally and distally to identify the muscles overlying the 3rd and 6th ribs at the mid axillary line. Using in- plane approach, a 22-gauge short bevel needle is inserted and advanced to the plane deep to the serratus anterior muscle at the level of 3rd and 6th ribs bilaterally in succession over which a total volume of 1.5ml/kg bupivacaine 0.125% is divided and injected (0.75ml/kg on each side); with total dose not exceeding 2.5 mg/kg.

Intervention: Bilateral two level serratus anterior block (Procedure)

Outcomes

Primary Outcomes

Postoperative Fentanyl consumption

Time Frame: in the first 24 hours post-operatively

Secondary Outcomes

  • Postoperative Face, Leg, Activity, Cry, Consolability "FLACC" pain scale(at 1, 2, 4, 8, 12, and 24 hours post-operatively)
  • Time to first rescue analgesia(recorded during the first 24 hours after surgery (in hours unit))
  • Time to extubation(24 hours post-operatively)
  • Incidence of complications(24 hours post-operatively)
  • intraoperative heart rate(Intraoperative period)
  • Intraoperative systolic blood pressure(Intraoperative period)
  • Intraoperative additional boluses of fentanyl(Intraoperative period)
  • Postoperative heart rate(at 1, 2, 4, 8, 12, and 24 hours post-operatively)
  • Postoperative systolic blood pressure(at 1, 2, 4, 8, 12, and 24 hours post-operatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mai Madkour

Associate professor

Cairo University

Study Sites (1)

Loading locations...

Similar Trials